| S. No. | Duration | Biotech-Startups supported - Current (No.) | Beneficieries - Current (No.) | DBT-JRF Supported - Current (No.) |
|---|---|---|---|---|
| 1 | Qtr-2 (2018-19) | 507 | 235 | 957 |
| 2 | Qtr-3 (2018-19) | 562 | 358 | 978 |
| 3 | Qtr-4 (2018-19) | 588 | 359 | 1,008 |
| 4 | Qtr-1 (2019-20) | 640 | 416 | 880 |
| 5 | Qtr-2 (2019-20) | 686 | 462 | 962 |
| 6 | Qtr-3 (2019-20) | 714 | 475 | 970 |
| 7 | Qtr-4 (2019-20) | 723 | 530 | 984 |
| 8 | Qtr-1 (2020-21) | 778 | 4,206 | 766 |
| 9 | Qtr-2 (2020-21) | 631 | 29,836 | 780 |
| 10 | Qtr-3 (2020-21) | 691 | 31,731 | 767 |
| 11 | Qtr-4 (2020-21) | 720 | 35,988 | 809 |
| 12 | Qtr-1 (2021-22) | 275 | 8,347 | 853 |
| 13 | Qtr-2 (2021-22) | 223 | 11,104 | 920 |
| 14 | Qtr-3 (2021-22) | 32 | 82,249 | 861 |
| 15 | Qtr-4 (2021-22) | 27 | 8,874 | 1,065 |
| 16 | Qtr-1 (2022-23) | 18 | 9,718 | 168 |
| 17 | Qtr-2 (2022-23) | 24 | 16,692 | 163 |
| 18 | Qtr-3 (2022-23) | 21 | 22,500 | 177 |
| 19 | Qtr-4 (2022-23) | 44 | 129,133 | 174 |
| 20 | Qtr-1 (2023-24) | 17 | 12,114 | 195 |
| 21 | Qtr-2 (2023-24) | 66 | 9,803 | 204 |
| 22 | Qtr-3 (2023-24) | 17 | 5,437 | 183 |
| 23 | Qtr-4 (2023-24) | 29 | 9,639 | 183 |
| 24 | Qtr-2 (2024-25) | 12 | 10,028 | 229 |
